4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

767.50p
   
  • Change Today:
    -17.50p
  • 52 Week High: 1,337.50
  • 52 Week Low: 703.85
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 0
  • Market Cap: £119.26m
  • Beta: 0.03

Latest Deals

Traded Action Notifier PriceAmountValue
29-Sep-25 Buy Heikki Lanckriet 749.00p 2,000 £14,980.00
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
29-Sep-25 Buy Heikki Lanckriet 749.00p 2,000 £14,980.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,119,688 £8,593,605
Amy Walker 44,016 £337,823
Hansjörg Plaggemars 6,667 £51,169

Major Shareholders

Notifier** Holding Value*
Wilhelm K. T. Zours 5,119,743 £39,294,028
DELPHI Unternehmensberatung AG 5,119,743 £39,294,028
4bb AG 5,115,852 £39,264,164
M&G Plc 4,627,741 £35,517,912
Elevage Medical Technologies Holdings 4,627,741 £35,517,912
Deutsche Balaton AG 4,432,637 £34,020,489
2invest AG 2,229,083 £17,108,212
Sparta AG 1,351,718 £10,374,436
Latonba AG 778,891 £5,977,988
Franciscus De Busschere 537,255 £4,123,432

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 767.50p
Change Today -17.50p
% Change -2.23 %
52 Week High 1,337.50
52 Week Low 703.85
Volume 0
Shares Issued 15.54m
Market Cap £119.26m
Beta 0.03

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average
12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average
Price Trend
34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average
4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average
Income Not Available
Growth
59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average

4basebio Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page